Executive Summary
The 9 filings in the India MCA Insolvency & Restructuring Monitor reveal a landscape dominated by prolonged Corporate Insolvency Resolution Processes (CIRPs) in infrastructure, textiles, and finance sectors, with 4 companies (Setubandhan, Morarjee Textiles, Reliance Home Finance, VAS Infrastructure) showing no resolution progress despite multi-year proceedings. Restructuring via amalgamations advances positively in healthcare (Aster DM meetings held, Indo National scheme sanctioned by NCLT Chennai on March 10, 2026), contrasting neutral voluntary liquidations of minor subsidiaries in IT/diagnostics (Tech Mahindra, Dr. Lal PathLabs) with negligible impact (e.g., Tech sub AUD 10.02 Mn revenue FY25, Dr Lal sub 7.37% turnover FY24). Limited financial data highlights distress: Setubandhan FY25 net loss ₹1.51 Cr on ₹23.22 L turnover amid persistent audit qualifications since FY23. No YoY/QoQ trends across portfolio due to sparse disclosures, but repetitive audit issues and rejected plans signal deteriorating net worth (Setubandhan ₹45.14 Cr). New filings (first 3) underscore Aster DM's scheme momentum and Setubandhan's stalled FY25 reporting. Overall, 5/9 neutral/negative sentiments indicate sector-wide distress, with catalysts like VAS NCLT hearing on March 20 offering turnaround potential. Market implication: Avoid prolonged CIRPs, monitor restructuring completions for alpha.
Tracking the trend? Catch up on the prior India MCA Insolvency Liquidation Filings digest from March 09, 2026.
Investment Signals(11)
- Setubandhan Infrastructure↓(BEARISH)▲
FY25 net loss ₹1.51 Cr (EPS -₹0.15) on ₹23.22 L turnover, total assets/liabilities ₹169.70 Cr, persistent audit qualifications since FY23 including unconfirmed balances and no subsidiary disclosures, resolution plan rejected by NCLT March 2025
- Morarjee Textiles↓(BEARISH)▲
35th CoC meeting on March 10, 2026, under CIRP since Feb 2024 with no operational/financial updates or resolution, signaling ongoing distress
- Reliance Home Finance↓(BEARISH)▲
7th CoC meeting March 9, 2026, post CIRP start Sept 2025, no outcomes or financial details disclosed
- VAS Infrastructure(BULLISH)▲
NCLT Mumbai to consider Authum resolution plan on March 20, 2026 (IA 41/2025), potential exit from ongoing CIRP
- Aster DM Healthcare (Shareholders)▲
Equity meeting March 10, 2026, for Quality Care amalgamation scheme per NCLT Jan 21 order, e-voting March 6-9 concluded, results pending [NEUTRAL->BULLISH]
- Aster DM Healthcare (Creditors)▲
Unsecured trade creditors meeting March 10, 2026, for same scheme, 51 attendees, e-voting results to exchanges soon [NEUTRAL->BULLISH]
- Indo National(BULLISH)▲
NCLT Chennai sanctioned Helios Strategic Systems amalgamation March 10, 2026, effective post ROC filing, positive restructuring completion
- Tech Mahindra(NEUTRAL)▲
Voluntary liquidation of Tech Mahindra Digital Pty (step-down sub) effective March 9, 2026, minor FY25 revenue AUD 10.02 Mn (negligible to parent) with no liabilities
- Dr. Lal PathLabs(NEUTRAL)▲
Completed voluntary liquidation of Suburban Diagnostics sub, NCLT order Feb 27/ received March 9, 2026; sub contributed 7.37% consolidated turnover (₹164 Cr) FY24, business consolidated March 2025
- Setubandhan vs VAS Infra (relative)▲
Setubandhan CIRP since Nov 2022 with rejected plan vs VAS upcoming NCLT review, highlighting relative outperformance risk in resolution timelines [BEARISH for Setubandhan]
- Healthcare Restructuring (Aster/Indo)(BULLISH)▲
3/9 filings show scheme progress vs 4/9 stalled CIRPs, sector relative strength
Risk Flags(8)
- Setubandhan Infrastructure/Audit↓[HIGH RISK]▼
Repetitive FY23-FY25 qualifications (unconfirmed balances, unrevalued assets, no bank confirmations, subsidiary disclaimers), delayed FY25 results due to management failure
- Setubandhan/Resolution↓[HIGH RISK]▼
CoC-approved plan rejected NCLT Mumbai March 24, 2025, appeal pending NCLAT since July 2025, net worth ₹45.14 Cr amid ₹169.70 Cr liabilities
- Morarjee Textiles/CIRP Duration↓[HIGH RISK]▼
35th CoC meeting March 10, 2026, 2+ years into CIRP (NCLT Feb 2024), no resolution or ops updates
- Reliance Home Finance/Disclosure↓[MEDIUM RISK]▼
7th CoC March 9, 2026, no meeting outcomes shared, CIRP ongoing since Sept 2025
- VAS Infrastructure/Hearing[MEDIUM RISK]▼
NCLT review of Authum plan March 20, 2026, risk of rejection prolonging CIRP
- Setubandhan FY25 Ops[HIGH RISK]▼
Turnover ₹23.22 L vs ₹1.74 Cr expenses, net loss ₹1.51 Cr signals operational collapse
- Infra/Textile Cluster[SECTOR RISK]▼
3/9 filings (Setubandhan, Morarjee, VAS) in prolonged CIRP, average 2+ years, no YoY financial trends improving
- Aster DM/Voting↓[MEDIUM RISK]▼
Scheme e-voting results pending post March 10 meetings, potential shareholder/creditor rejection
Opportunities(8)
- VAS Infrastructure/NCLT Hearing(OPPORTUNITY)◆
Monitor Authum resolution plan approval March 20, 2026, potential CIRP exit and value unlock in distressed asset
- Indo National/Scheme Sanction(OPPORTUNITY)◆
NCLT-approved amalgamation March 10, 2026, effective post ROC filing, consolidation alpha for NIPPOBATRY holders
- Aster DM Healthcare/Scheme Results↓(OPPORTUNITY)◆
Shareholders/creditors meetings March 10 with e-voting done, imminent results announcement could trigger scheme approval and merger arbitrage
- Dr. Lal PathLabs/Liquidation Complete(OPPORTUNITY)◆
Suburban sub dissolved March 2026, 7.05% net worth (₹126.62 Cr) FY24 consolidated into parent, cleaner BS post March 2025 transfer
- Tech Mahindra/Sub Cleanup(OPPORTUNITY)◆
Minor sub liquidation March 9, 2026 (AUD 10.89 Mn NW FY25), no liabilities, enhances parent focus
- Healthcare Consolidation (Aster/Indo)(OPPORTUNITY)◆
3 filings show NCLT-driven amalgamations progressing vs stalled CIRPs elsewhere, relative sector turnaround
- Setubandhan/Appeal Outcome↓(OPPORTUNITY)◆
Pending NCLAT appeal on rejected plan (filed July 2025), RP AFA valid to Dec 2026, potential reversal catalyst
- Morarjee Textiles/35th CoC↓(OPPORTUNITY)◆
March 10, 2026 meeting under RP Ravi Sethia, watch for resolution progress in textiles distress
Sector Themes(6)
- Prolonged CIRPs in Infra/Finance/Textiles(BEARISH SECTOR)◆
4/9 filings (Setubandhan since 2022, Morarjee 35th CoC, Reliance 7th CoC, VAS) with no resolutions, repetitive audit issues and delays vs quick liquidations elsewhere, implies 2+ year timelines eroding value
- Healthcare Restructuring Momentum(BULLISH RELATIVE)◆
3/9 filings (Aster DM dual meetings, Indo National sanction March 10) show NCLT-directed schemes advancing with e-voting complete, contrasting stalled CIRPs
- Voluntary Liquidations Minor Impact(NEUTRAL)◆
2/9 (Tech Mahindra AUD 10 Mn rev sub, Dr Lal 7% turnover sub) clean balance sheet exercises with no liabilities, average <8% contribution, signals efficient sub pruning
- Audit/Disclosure Weakness in Distress(BEARISH)◆
Setubandhan FY25 qualifications mirror FY23 patterns (unconfirmed balances, no revaluations), no portfolio-wide YoY improvements, heightens opacity risk
- NCLT Catalysts Cluster March 2026(THEME)◆
VAS hearing March 20, Indo sanction/ Aster results imminent, potential wave of resolutions post Jan/Feb orders
- No Capital Allocation/Insider Signals(CAUTION)◆
Zero dividends/buybacks/insider trades across 9 filings, focus on survival/restructuring over returns
Watch List(8)
- VAS Infrastructure/NCLT Hearing👁
Authum resolution plan consideration by NCLT Mumbai, IA 41/2025 on March 20, 2026 - approval could end CIRP
Shareholders and creditors e-voting results post March 10, 2026 meetings to be filed with exchanges - scheme approval catalyst
- Indo National/Scheme Effective👁
Await certified NCLT order copy and ROC filing post March 10, 2026 sanction - track stock exchange intimation
Pending appeal on rejected resolution plan since July 9, 2025 - monitor outcome amid RP AFA to Dec 31, 2026
Outcomes from March 10, 2026 meeting under RP Ravi Sethia - any resolution updates
Post 7th CoC March 9, 2026 - watch for delayed disclosures on decisions
- Dr. Lal PathLabs/NCLT Compliance👁
Liquidator to file order with ROC within 14 days of March 9, 2026 receipt - confirm dissolution
- Tech Mahindra/Liquidation Finality👁
Step-down sub dissolution post March 9, 2026 - any residual impacts
Filing Analyses(9)
10-03-2026
Setubandhan Infrastructure Limited, undergoing CIRP since November 28, 2022 initiated by State Bank of India, held an RP meeting on December 1, 2025, to note the delay in submitting audited FY25 standalone financial results beyond the 60-day deadline, attributed to suspended management's failure to provide books and records. FY25 results show turnover of ₹23.22 L, total expenditure of ₹1.74 Cr, and net loss of ₹1.51 Cr, with total assets and liabilities both at ₹169.70 Cr and net worth of ₹45.14 Cr; however, the audit carries multiple qualified opinions including unconfirmed balances, unrevalued assets, missing bank confirmations, and disclaimer on subsidiaries and related parties. A CoC-approved resolution plan was rejected by NCLT Mumbai on March 24, 2025, with an appeal pending before NCLAT since July 9, 2025.
- ·Audit qualifications are repetitive since FY23 for most items, including qualified opinion on balance confirmations, liabilities not restated per CIRP claims, assets not revalued, no bank statements for certain accounts, disclaimer on subsidiaries' CARO reports, and related party transactions not disclosed.
- ·EPS for FY25: (₹0.15).
- ·RP's AFA valid up to December 31, 2026.
- ·NSE Symbol: SETUINFRA; BSE Scrip Code: 533605.
10-03-2026
Aster DM Healthcare Limited held an equity shareholders' meeting on March 10, 2026, at 10:00 A.M. IST via VC/OAVM, as directed by the NCLT Hyderabad bench's order dated January 21, 2026, to consider and approve the Scheme of Amalgamation with Quality Care India Limited. The meeting, chaired by Advocate Ms. Sandhya Rani, was attended by 64 members, with remote e-voting from March 6 to March 9, 2026, and e-voting during the meeting; results are to be announced later. Ms. Alisha Moopen addressed the salient features of the scheme and responded to shareholder queries.
- ·NCLT Order dated January 21, 2026, directing the meeting
- ·Remote e-voting period: March 6, 2026 (9:00 A.M.) to March 9, 2026 (5:00 P.M.)
- ·Meeting concluded at 10:55 A.M. IST
- ·Disclosure pursuant to Regulation 30 of SEBI Listing Regulations
10-03-2026
Aster DM Healthcare Limited (Transferee Company) convened a meeting of its unsecured trade creditors on March 10, 2026, pursuant to NCLT Hyderabad bench order dated January 21, 2026, to consider and approve the Scheme of Amalgamation with Quality Care India Limited (Transferor Company). The meeting, held via VC/OAVM at 02:00 P.M. IST and chaired by Ms. KVS Madhumita, was attended by 51 unsecured trade creditors, with remote e-voting conducted from March 6 to March 9, 2026. Voting results and scrutinizer report are to be disseminated to stock exchanges post-meeting.
- ·Remote e-voting: March 6, 2026 (9:00 A.M. IST) to March 9, 2026 (5:00 P.M. IST)
- ·NCLT Order date: January 21, 2026
- ·Prior letter date: February 4, 2026
- ·Meeting concluded at 02:45 P.M. IST
10-03-2026
Morarjee Textiles Limited, under Corporate Insolvency Resolution Process (CIRP) of the Insolvency and Bankruptcy Code 2016, has notified stock exchanges of its Thirty Fifth Committee of Creditors (COC) meeting scheduled for 10 March 2026 at 3:00 p.m. The company's affairs are managed by Resolution Professional Mr. Ravi Sethia, appointed by NCLT Mumbai on 09 February 2024 and confirmed by COC on 22 May 2024. This ongoing insolvency process signals continued financial distress with no resolution or operational updates provided.
- ·NCLT order: CP(IB) No. 1318/MB-VI/2022 dated 09 February 2024.
- ·Company CIN: L52322MH1995PLC090643.
- ·Compliance pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 and Schedule III Clause A Part A sub-clause 16(g).
10-03-2026
Resolution Professional Umesh B. Sonkar provided post-facto intimation of the 7th Meeting of the Committee of Creditors (CoC) for Reliance Home Finance Limited (under CIRP), held on March 9, 2026, at 03:30 P.M. IST via video conferencing. This follows the CIRP initiation intimated on September 20, 2025. No outcomes, decisions, or financial details from the meeting were disclosed.
- ·BSE Scrip Code: 540709
- ·NSE Symbol: RHFL
- ·ISIN: INE217K01011
- ·RP Registration: IBBI/IPA-001/IP-P-02619/2021-2022/14043 (valid upto December 31, 2026)
- ·CIRP initiation reference intimation: September 20, 2025
10-03-2026
Tech Mahindra Ltd announced the voluntary liquidation of its step-down wholly-owned subsidiary, Tech Mahindra Digital Pty Ltd, effective March 9, 2026, with intimation received on March 10, 2026. The subsidiary contributed AUD 10.02 Mn in revenue and had a net worth of AUD 10.89 Mn for the financial year ended March 31, 2025, representing a minor portion of the parent's operations. No sale consideration or related party transactions were involved.
- ·Liquidation intimation received by Tech Mahindra Ltd on March 10, 2026 at 10.56 AM (IST)
- ·Subsidiary is wholly-owned by Tech Mahindra (Singapore) Pte Limited
10-03-2026
VAS Infrastructure Limited, currently under Corporate Insolvency Resolution Process (CIRP), has provided prior intimation that the Hon'ble NCLT Mumbai Bench will consider the Resolution Plan submitted by Authum Investment & Infrastructure Limited on March 20, 2026 (IA no. 41 of 2025). This update is issued pursuant to Regulation 30 of SEBI LODR Regulations, 2015, amid the company's ongoing insolvency proceedings.
- ·CIN: L65100MH1994PLC076538
- ·Scrip No.: 531574 (BSE)
- ·IA No.: 41 of 2025
- ·IBBI Reg. No.: IBBI/IPA-002/IP-N000932/2019-20/12973 (Valid upto 31.12.2026)
- ·Resolution Professional Address: Flat No. B 703/704, Seventh Floor, River Park CHS Ltd., Dattani Park Road, Thakur Village, Kandivali (East), Mumbai - 400101
10-03-2026
Dr. Lal PathLabs Limited announced the completion of voluntary liquidation of its wholly-owned subsidiary Suburban Diagnostics (India) Private Limited, with NCLT Mumbai Bench approving dissolution via order reserved on February 27, 2026, received on March 9, 2026. The subsidiary's entire business undertaking was consolidated into the parent effective close of business on March 18, 2025, with no outstanding liabilities. As of March 31, 2024, Suburban contributed ₹164.03 Cr to turnover (7.37% of consolidated) and ₹126.62 Cr to net worth (7.05% of consolidated).
- ·Suburban Diagnostics incorporated on June 6, 2002.
- ·Board of Directors approved voluntary liquidation on February 6, 2025; shareholders passed special resolution on same date appointing liquidator.
- ·NCLT order directs liquidator to file copy with Registrar of Companies within 14 days and preserve records for 8 years.
- ·Voluntary liquidation bank account closed on February 17, 2026 with NIL balance.
10-03-2026
The Hon’ble National Company Law Tribunal, Chennai Bench sanctioned the Scheme of Amalgamation of Helios Strategic Systems Limited (Transferor Company) with Indo National Limited (Transferee Company) on March 10, 2026, in accordance with Sections 230-232 of the Companies Act, 2013. The certified copy of the Order is awaited, and the scheme will become effective upon filing with the Registrar of Companies, Chennai. Indo National Limited will intimate stock exchanges upon receipt of the order.
- ·Scrip Code: 504058 (BSE), NSE Symbol: NIPPOBATRY
- ·Corporate office: Pottipati Plaza, 3rd Floor, 77, Nungambakkam High Road, Chennai – 600034
- ·Registered office: No. 609, Mount Road, Lakshmi Bhawan IVth Floor, Chennai-600006
- ·CIN No: L31909TN1972PLC006196
Get daily alerts with 11 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 9 filings
🇮🇳 More from India
View all →March 26, 2026
India Pre-Market Regulatory Roundup — March 26, 2026
India Pre-Market Regulatory Roundup
March 26, 2026
India Quarterly Results BSE NSE Announcements — March 26, 2026
India Quarterly Results BSE NSE Announcements
March 26, 2026
India Upcoming Corporate Actions BSE NSE — March 26, 2026
India Upcoming Corporate Actions BSE NSE
March 26, 2026
India RBI Banking Regulatory Enforcement Actions — March 26, 2026
India RBI Banking Regulatory Enforcement Actions